The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 01, 2021
Filed:
Dec. 18, 2018
Applicants:
Janssen Sciences Ireland Unlimited Company, County Cork, IE;
Bavarian Nordic A/s, Kvistgaard, DK;
Inventors:
Daniel Boden, San Mateo, CA (US);
Helen Horton, Mol, BE;
Jean-Marc Edmond Fernand Marie Neefs, Lier, BE;
Soumitra Roy, Townsend, DE (US);
JerĂ´me Hubertina Henricus Victor Custers, Alphen aan den Rijn, NL;
Roland Christian Zahn, Rijnsburg, NL;
Markus Kalla, Penzberg, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/29 (2006.01); C12N 15/86 (2006.01); A61K 39/12 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/292 (2013.01); A61K 39/12 (2013.01); C12N 15/86 (2013.01); A61K 2039/545 (2013.01); A61K 2039/70 (2013.01); C12N 2710/10043 (2013.01); C12N 2710/24143 (2013.01); C12N 2730/10134 (2013.01);
Abstract
Provided herein are Modified Vaccinia Ankara (MVA) vectors and adenovirus vectors encoding HBV antigens. Also provided are methods of enhancing an immune response in a human subject by utilizing the MVA and adenovirus vectors encoding HBV antigens in a prime/boost regimen to the enhance the immune response in the human subject.